EMEA-000917-PIP01-10-M04 - paediatric investigation plan

bimatoprost

Key facts

• Invented name:
  • Lumigan and associated names
  • Lumigan
• Active substance:
  bimatoprost
• Therapeutic area:
  Dermatology
• Decision number:
  P/0293/2014
• PIP number:
  EMEA-000917-PIP01-10-M04
• Pharmaceutical form(s):
  • Eye drops, solution
  • Cutaneous solution
  • Ophthalmic insert
• Condition(s) / indication(s):
  • Treatment of glaucoma
  • Treatment of non-scarring hair loss
• Route(s) of administration:
  • Ocular use
  • Cutaneous use
  • Intraocular use
• Decision type:
  PM: decision on the application for modification of an agreed PIP
• Decision date:
  30/10/2014
• Compliance check done:
  No

Decision

P/0293/2014: EMA decision of 30 October 2014 on the acceptance of a modification of an agreed paediatric investigation plan for bimatoprost (Lumigan and associated names) (EMEA-000917-PIP01-10-M04)

Adopted Reference Number: EMA/624333/2014